CO4410189A1 - Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo - Google Patents
Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)iloInfo
- Publication number
- CO4410189A1 CO4410189A1 CO95029779A CO95029779A CO4410189A1 CO 4410189 A1 CO4410189 A1 CO 4410189A1 CO 95029779 A CO95029779 A CO 95029779A CO 95029779 A CO95029779 A CO 95029779A CO 4410189 A1 CO4410189 A1 CO 4410189A1
- Authority
- CO
- Colombia
- Prior art keywords
- beta
- alpha
- tax
- oxo
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Abstract
UN PROCEDIMIENTO DE PREPARACION DE TRIHIDRATO DE (2R.3S)-3-TERT-BUTOXICARBONILAMINO-2HIDROXI-3- FENIL PROPIONATO DE 4-ACETOXI-2A-BEZOILOXI-5B, 20- EPOXI-1,7B, 10B -TRIHIDROXI -9-OXO-TAX-11-EN-13 - ILO CARACTERIZADO EN QUE SE CRISTALIZA EL TRIHI- DRATO DE (2R.3S) --3-TERT-BUTOXI CARBONILAMINO-2- HIDROXI-3-FENILPROPIONATO DE 4-ACETOXI-2 - BENZO- ILOXI-5B, 20-EPOXI-1,7B,10B-TRIHIDROXI-9OXO-TAX-11 EN-13 -ILO DENTRO DE UNA MEZCLA DE AGUA Y DE UN ALCOHOL ALIFATICO QUE CONTIENE 1 A 3 ATOMOS DE CARBONO, LUEGO SE SECA EL PRODUCTO OBTENIDO BAJO LAS CONDICIONES DETERMINADAS DE TEMPERATURA, DE PRESION Y DE HUMEDAD.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9408479A FR2722191B1 (fr) | 1994-07-08 | 1994-07-08 | Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle |
Publications (1)
Publication Number | Publication Date |
---|---|
CO4410189A1 true CO4410189A1 (es) | 1997-01-09 |
Family
ID=9465183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO95029779A CO4410189A1 (es) | 1994-07-08 | 1995-07-07 | Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo |
Country Status (38)
Country | Link |
---|---|
US (1) | US6022985A (es) |
EP (1) | EP0770070B1 (es) |
JP (1) | JP3753155B2 (es) |
KR (1) | KR100391753B1 (es) |
CN (1) | CN1067996C (es) |
AT (1) | ATE171702T1 (es) |
AU (1) | AU706519B2 (es) |
BR (1) | BR9508789A (es) |
CA (1) | CA2193531C (es) |
CO (1) | CO4410189A1 (es) |
CZ (1) | CZ284695B6 (es) |
DE (1) | DE69505128T2 (es) |
DK (1) | DK0770070T3 (es) |
DZ (1) | DZ1905A1 (es) |
ES (1) | ES2121404T3 (es) |
FI (1) | FI119246B (es) |
FR (1) | FR2722191B1 (es) |
GR (1) | GR3027558T3 (es) |
HU (1) | HU220634B1 (es) |
IL (1) | IL114274A (es) |
IN (1) | IN183947B (es) |
IS (1) | IS2032B (es) |
MA (1) | MA23606A1 (es) |
MX (1) | MX9700173A (es) |
MY (1) | MY118481A (es) |
NO (1) | NO314500B1 (es) |
NZ (1) | NZ289455A (es) |
PE (1) | PE8697A1 (es) |
PL (1) | PL179876B1 (es) |
RU (1) | RU2126397C1 (es) |
SI (1) | SI0770070T1 (es) |
SK (1) | SK280520B6 (es) |
TN (1) | TNSN95071A1 (es) |
TW (1) | TW419473B (es) |
UA (1) | UA51624C2 (es) |
UY (1) | UY23991A1 (es) |
WO (1) | WO1996001815A1 (es) |
ZA (1) | ZA955646B (es) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL336523A1 (en) | 1997-04-28 | 2000-07-03 | Rhone Poulenc Rorer Sa | Intraneoplastic delivery of an angiogenesis antagonist by means of adenoviruses in order to treat neoplasms |
SE510650C2 (sv) | 1997-05-30 | 1999-06-14 | Astra Ab | Ny förening |
FR2794771B1 (fr) | 1999-06-11 | 2001-08-10 | Aventis Pharma Sa | Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis) |
US6266619B1 (en) * | 1999-07-20 | 2001-07-24 | Halliburton Energy Services, Inc. | System and method for real time reservoir management |
US6853921B2 (en) | 1999-07-20 | 2005-02-08 | Halliburton Energy Services, Inc. | System and method for real time reservoir management |
GB9920548D0 (en) * | 1999-08-31 | 1999-11-03 | Rhone Poulenc Rorer Sa | Treatment of hepatocellular carcinoma |
US6891050B2 (en) * | 2001-08-10 | 2005-05-10 | Dabur India Limited | Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs |
US6881852B2 (en) * | 2002-02-05 | 2005-04-19 | Dabur India Limited | Process of purification of paclitaxel and docetaxel |
US7247738B2 (en) * | 2002-05-07 | 2007-07-24 | Dabur India Limited | Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids |
US6900342B2 (en) * | 2002-05-10 | 2005-05-31 | Dabur India Limited | Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof |
US6838569B2 (en) * | 2002-12-16 | 2005-01-04 | Dabur India Limited | Process for preparation of paclitaxel trihydrate and docetaxel trihydrate |
US7584165B2 (en) * | 2003-01-30 | 2009-09-01 | Landmark Graphics Corporation | Support apparatus, method and system for real time operations and maintenance |
US8703982B2 (en) * | 2003-03-17 | 2014-04-22 | Phyton Holdings Llc | Purification of taxanes |
CN1268619C (zh) * | 2003-05-08 | 2006-08-09 | 上海迪赛诺化学制药有限公司 | 多烯紫杉醇三水化合物的制备方法 |
WO2005061474A1 (en) | 2003-12-12 | 2005-07-07 | Quiral Química Do Brasil | Process for the preparation of anhydrous and hydrated active pharmaceutical ingredients (apis); stable pharmaceutical compositions prepared from the same and uses of said compositions |
US7142986B2 (en) * | 2005-02-01 | 2006-11-28 | Smith International, Inc. | System for optimizing drilling in real time |
CN100420681C (zh) * | 2005-04-29 | 2008-09-24 | 上海奥锐特国际贸易有限公司 | 多烯紫杉醇三水物的制备方法 |
CN101291659A (zh) * | 2005-08-31 | 2008-10-22 | 阿布拉科斯生物科学有限公司 | 包含水难溶性药剂和抗微生物剂的组合物 |
US8034765B2 (en) * | 2005-08-31 | 2011-10-11 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
US20070142457A1 (en) * | 2005-10-12 | 2007-06-21 | Alessandro Pontiroli | Crystalline forms of docetaxel and processes for their preparation |
KR100995390B1 (ko) | 2006-01-02 | 2010-11-19 | 주식회사 삼양제넥스 | 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법 |
EP1999492A4 (en) * | 2006-01-20 | 2011-05-18 | Landmark Graphics Corp | DYNAMIC PRODUCTION MANAGEMENT SYSTEM |
KR20080100264A (ko) * | 2006-03-21 | 2008-11-14 | 닥터 레디스 레보러터리즈 리미티드 | 도세탁셀의 다형체와 그 제조방법 |
EP2330101A1 (en) * | 2006-10-20 | 2011-06-08 | Scinopharm Singapore Pte, Ltd. | Process for making crystalline docetaxel |
KR100868116B1 (ko) | 2007-04-09 | 2008-11-10 | 한미약품 주식회사 | 도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법 |
KR100878455B1 (ko) * | 2007-04-10 | 2009-01-13 | 한미약품 주식회사 | 안정한 무수결정형 도세탁셀 및 이의 제조방법 |
US20100197944A1 (en) * | 2007-07-04 | 2010-08-05 | Dr. Reddy's Laboratories Limited | Docetaxel process and polymorphs |
EP2080763A1 (en) * | 2008-01-18 | 2009-07-22 | INDENA S.p.A. | Crystalline form I of ortataxel |
EP2080764B1 (en) | 2008-01-18 | 2012-08-22 | INDENA S.p.A. | Solid forms of ortataxel |
PL388144A1 (pl) | 2009-05-29 | 2010-12-06 | Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością | Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie |
ES2621613T3 (es) | 2009-11-04 | 2017-07-04 | Emcure Pharmaceuticals Limited | Un proceso mejorado para la preparación de derivados de taxano |
CN102970990A (zh) | 2010-05-03 | 2013-03-13 | 帝国制药美国公司 | 非水性紫杉烷前-乳剂制剂以及制备和使用该制剂的方法 |
WO2012160568A1 (en) * | 2011-05-23 | 2012-11-29 | Shilpa Medicare Limited | Process for preparing docetaxel trihydrate polymorph |
DK2753355T3 (en) | 2011-09-08 | 2019-01-28 | Univ New York | ONCOLYTIC HERP SIMPLEX VIRUSES AND THERAPEUTIC APPLICATIONS THEREOF |
WO2013096455A1 (en) | 2011-12-20 | 2013-06-27 | Dana-Farber Cancer Institute, Inc. | Methods for diagnosing and treating oncogenic kras-associated cancer |
SI2833905T1 (en) | 2012-04-04 | 2018-08-31 | Halozyme, Inc. | Combination therapy with hyaluronidase and tumane-directed taxane |
CA2874521A1 (en) | 2012-05-24 | 2013-11-28 | Dana-Farber Cancer Institute, Inc. | Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer |
US20150285802A1 (en) | 2012-07-18 | 2015-10-08 | Dana-Farber Cancer Institute, Inc. | Methods for treating, preventing and predicting risk of developing breast cancer |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
WO2014149871A1 (en) | 2013-03-14 | 2014-09-25 | Icahn School Of Medicine At Mount Sinai | Autologous tumor lysate-loaded dendritic cell vaccine for treatment of liver cancer |
WO2015050844A1 (en) | 2013-10-01 | 2015-04-09 | Dana-Farber Cancer Institute, Inc. | Methods of treating cancer with atovaquone-related compounds |
US10350264B2 (en) | 2014-03-27 | 2019-07-16 | Dana-Farber Cancer Institute, Inc. | Compositions and methods for modulating NCOA4-mediated autophagic targeting of ferritin |
MA39818A (fr) | 2014-03-30 | 2017-02-08 | Benevir Biopharm Inc | Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques |
WO2016205429A1 (en) | 2015-06-15 | 2016-12-22 | New York University | Method of treatment using oncolytic viruses |
WO2019222435A1 (en) | 2018-05-16 | 2019-11-21 | Halozyme, Inc. | Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
US5229526A (en) * | 1991-09-23 | 1993-07-20 | Florida State University | Metal alkoxides |
-
1994
- 1994-07-08 FR FR9408479A patent/FR2722191B1/fr not_active Expired - Fee Related
-
1995
- 1995-06-22 IL IL11427495A patent/IL114274A/xx not_active IP Right Cessation
- 1995-07-03 UY UY23991A patent/UY23991A1/es not_active IP Right Cessation
- 1995-07-04 DZ DZ950082A patent/DZ1905A1/fr active
- 1995-07-05 TN TNTNSN95071A patent/TNSN95071A1/fr unknown
- 1995-07-05 PE PE1995272899A patent/PE8697A1/es not_active IP Right Cessation
- 1995-07-06 MY MYPI95001895A patent/MY118481A/en unknown
- 1995-07-06 MA MA23945A patent/MA23606A1/fr unknown
- 1995-07-06 IN IN1260DE1995 patent/IN183947B/en unknown
- 1995-07-06 ZA ZA955646A patent/ZA955646B/xx unknown
- 1995-07-06 TW TW084106974A patent/TW419473B/zh not_active IP Right Cessation
- 1995-07-07 AT AT95925022T patent/ATE171702T1/de active
- 1995-07-07 US US08/776,333 patent/US6022985A/en not_active Expired - Lifetime
- 1995-07-07 SK SK6-97A patent/SK280520B6/sk not_active IP Right Cessation
- 1995-07-07 PL PL95318195A patent/PL179876B1/pl unknown
- 1995-07-07 MX MX9700173A patent/MX9700173A/es unknown
- 1995-07-07 CA CA002193531A patent/CA2193531C/fr not_active Expired - Lifetime
- 1995-07-07 BR BR9508789A patent/BR9508789A/pt not_active Application Discontinuation
- 1995-07-07 DK DK95925022T patent/DK0770070T3/da active
- 1995-07-07 KR KR1019970700118A patent/KR100391753B1/ko not_active IP Right Cessation
- 1995-07-07 EP EP95925022A patent/EP0770070B1/fr not_active Expired - Lifetime
- 1995-07-07 HU HU9700041A patent/HU220634B1/hu unknown
- 1995-07-07 NZ NZ289455A patent/NZ289455A/en not_active IP Right Cessation
- 1995-07-07 ES ES95925022T patent/ES2121404T3/es not_active Expired - Lifetime
- 1995-07-07 WO PCT/FR1995/000910 patent/WO1996001815A1/fr active IP Right Grant
- 1995-07-07 AU AU29305/95A patent/AU706519B2/en not_active Expired
- 1995-07-07 RU RU97101875A patent/RU2126397C1/ru active
- 1995-07-07 CZ CZ9735A patent/CZ284695B6/cs not_active IP Right Cessation
- 1995-07-07 JP JP50415896A patent/JP3753155B2/ja not_active Expired - Fee Related
- 1995-07-07 UA UA97010077A patent/UA51624C2/uk unknown
- 1995-07-07 CO CO95029779A patent/CO4410189A1/es unknown
- 1995-07-07 CN CN95193984A patent/CN1067996C/zh not_active Expired - Lifetime
- 1995-07-07 SI SI9530138T patent/SI0770070T1/xx unknown
- 1995-07-07 DE DE69505128T patent/DE69505128T2/de not_active Expired - Lifetime
-
1997
- 1997-01-02 NO NO19970007A patent/NO314500B1/no not_active IP Right Cessation
- 1997-01-07 FI FI970069A patent/FI119246B/fi not_active IP Right Cessation
- 1997-01-07 IS IS4411A patent/IS2032B/is unknown
-
1998
- 1998-01-01 GR GR980400355T patent/GR3027558T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO4410189A1 (es) | Procedimiento de preparacion de trihidrato de (2r.3s) -3- tert-butoxicarbonilamino-2-hidroxi-3-fenilpropionato de 4-acetoxi-2(alfa)-bezoiloxi-5(beta),20-epoxi-1,7(beta),10 (beta)-trihidroxi-9-oxo-tax-11-en-13(alfa)ilo | |
FI793195A (fi) | Foerfarande foer framstaellning av ett aemne med bakteriostatisk aktivitet | |
DE59002863D1 (de) | Lysolecithinderivate zur behandlung von autoimmunerkrankungen. | |
ES2169188T3 (es) | Produccion de condimento. | |
BE875142A (fr) | Compositions anaerobies stabilisees contenant des acides | |
CO4700286A1 (es) | PROCEDIMIENTO DE PREPARACION DEL TRIHIDRATO DEL (2R,3S)-3- BENZOILAMINO-2-HIDROXI-3-FENILPROPIONATO DE 4,10-DIACETOXI- 2(alfa)-BENZOILOXI-5(beta),20-EPOXI-1,7(beta)-DIHIDROXI-9- OXO-TAX-11-EN 13(beta)-ILO | |
ES2120055T3 (es) | Procedimiento para la obtencion biotecnologica de alcoholes, aldehidos y acidos carboxilicos. | |
ES8101065A1 (es) | Procedimiento para la obtencion de 4,6-dioxa-5-alquil-trici-clo(7.2.1.0 2,8)-dodec-10-enos, de efecto aromatizante | |
HU9502542D0 (en) | Pharmaceutical composition | |
ES2026507T3 (es) | Procedimiento para la obtencion en continuo de compuestos alifaticos que contienen grupos carbalcoxi. | |
SE7506509L (sv) | Forfarande for framstellning av ett nytt antibiotikum kallat a-28086. | |
ES2094817T3 (es) | Procedimiento para la racemizacion de acidos 3-oxo-ciclopentano- o 3-oxo-ciclohexano-carboxilicos no racemicos, o de sus esteres con alcoholes c1-c6. | |
JPS53119285A (en) | Flocculant | |
ATE129636T1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines medikaments zur behandlung von ekzemen. | |
JPS54144319A (en) | Novel aminoglucopyranoside derivative its preparation, and oncostatic drugs comprising it as active constituent | |
ES2110194T3 (es) | Procedimiento de sintesis estereoespecifica de leucotrieno b4 en su configuracion 6z, 8e, 10e y productos intermedios. | |
ES410947A1 (es) | Procedimiento para preparar carbamatos de noracimetadol. |